R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/16378987

Download in:

View as

General Info

PMID
16378987